BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease

被引:3
|
作者
Hagen, Melanie [1 ]
Bucci, Laura [1 ]
Boeltz, Sebastian [1 ]
Noethling, Danae-Mona [1 ]
Rothe, Tobias [1 ]
Anoshkin, Kirill [1 ]
Raimondo, Maria G. [1 ]
Tur, Carlo [1 ]
Wirsching, Andreas [1 ]
Wacker, Jochen [1 ]
Duesing, Christina [2 ]
Distler, Jorg H. W. [2 ]
Kuwert, Torsten [1 ]
Bozec, Aline [1 ]
Ramming, Andreas [1 ]
Schett, Georg [1 ]
Grieshaber-Bouyer, Ricardo [1 ]
机构
[1] Friedrich Alexander Univ Erlangen Nuremberg, Erlangen, Germany
[2] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 09期
关键词
D O I
10.1056/NEJMc2408786
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:867 / 869
页数:3
相关论文
共 50 条
  • [21] Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy
    Hill, Joshua A.
    Kiem, Erika S.
    Bhatti, Atif
    Liu, Winnie
    Keane-Candib, Jacob
    Fitzpatrick, Kristin S.
    Boonyaratanakornkit, Jim
    Gardner, Rebecca A.
    Green, Damian J.
    Maloney, David G.
    Turtle, Cameron J.
    Smith, Jodi M.
    Gimferrer, Idoia
    Blosser, Christopher D.
    Jackson, Shaun W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (03) : 416 - 422
  • [22] Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy
    Ababneh, Hazim S.
    Yee, Andrew J.
    Raje, Noopur S.
    Martin, Sidney
    Frigault, Matthew J.
    Ng, Andrea K.
    Patel, Chirayu G.
    RADIOTHERAPY AND ONCOLOGY, 2023, 189
  • [23] Infectious Complications of BCMA-Targeted and CD19-Targeted Chimeric Antigen Receptor T-Cell Immunotherapy
    Kambhampati, Swetha
    Fakhri, Bita
    Sheng, Ying
    Huang, Chiung-Yu
    Byslma, Sophia
    Natsuhara, Kelsey
    Biswas, Dhruba
    Lo, Mimi
    Ai, Weiyun Z.
    Kaplan, Lawrence D.
    Martin, Thomas, III
    Wolf, Jeffrey L.
    Shah, Nina
    Andreadis, Charalambos
    Wong, Sandy W.
    BLOOD, 2020, 136
  • [24] Radiation therapy as bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy
    Ababneh, Hazim
    Yee, Andrew
    Raje, Noopur
    Martin, Sidney
    Frigault, Matthew
    Ng, Andrea
    Patel, Chirayu
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (10): : S31 - S32
  • [25] BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy
    Paul, Barry
    Rodriguez, Cesar
    Usmani, Saad Z.
    DRUGS, 2022, 82 (06) : 613 - 631
  • [26] BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy
    Barry Paul
    Cesar Rodriguez
    Saad Z. Usmani
    Drugs, 2022, 82 : 613 - 631
  • [27] Interventions and Outcomes of Multiple Myeloma Patients Progressing after BCMA-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Van Oekelen, Oliver
    Nath, Karthik
    Mouhieddine, Tarek H.
    Farzana, Tasmin
    Aleman, Adolfo
    Melnekoff, David T.
    Ghodke-Puranik, Yogita
    Jagannath, Sundar
    Shah, Urvi A.
    Mailankody, Sham
    Parekh, Samir
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S428 - S428
  • [28] A Comparative Analysis of Infectious Complications in Patients with Multiple Myeloma Treated with BCMA-Targeted Bispecific Antibodies and CAR T-Cell Therapy
    Nath, Karthik
    Shekarkhand, Tala
    Costa, Bruno Almeida
    Nemirovsky, David
    Derkach, Andriy
    Nishimura, Noriko
    Farzana, Tasmin
    Rueda, Colin
    Chung, David
    Landau, Heather
    Lahoud, Oscar Boutros
    Scordo, Michael
    Shah, Gunjan L.
    Hassoun, Hani
    Maclachlan, Kylee H.
    Korde, Neha
    Shah, Urvi A.
    Tan, Carlyn Rose
    Hultcrantz, Malin
    Giralt, Sergio A.
    Usmani, Saad Z.
    Shahid, Zainab
    Mailankody, Sham
    Lesokhin, Alexander
    BLOOD, 2023, 142
  • [29] Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies
    Keller, Alana L.
    Reiman, Lauren T.
    de Acha, Olivia Perez
    Parzych, Sarah E.
    Forsberg, Peter A.
    Kim, Peter S.
    Bisht, Kamlesh
    Wang, Hongfang
    van de Velde, Helgi
    Sherbenou, Daniel W.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (03): : 757 - 764
  • [30] Characterization of the BCMA epitope bound by BCMA-CD3 T cell engager elranatamab
    Josic, Maria
    Schweibold, Reece
    Mosyak, Lidia
    Chaparro-Riggers, Javier
    Baaten, Bas
    Bompiani-Myers, Kristin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)